Fundraising Fox

Eos Advisory

Impact investor

St Andrews · Seed–Growth · 10 people tracked

Also known as Kinburn (209) Llp

Fox Verdict
Sign up to see your fit

Investment thesis

Eos acts as a link between non-specialist investors and science- and technology-intensive companies. Its portfolio spans quality of life and environmental sustainability, covering disease diagnostics, prevention and treatment, food and water security, pollution reduction, clean energy and sustainable infrastructure. The firm seeks commensurate financial returns from early-stage patient capital while backing businesses that generate positive impact. Eos works in long-term partnerships with family offices, individuals, companies and institutional investors, operating across seed and growth stages on a managed or discretionary basis, from multistage multiyear relationships to angel syndicates. It offers S/EIS UK tax relief to eligible investors when available and is committed to diversity and inclusion.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Growth
HQ
St Andrews, GB
Leads rounds
Follows
Instruments
Equity
Founded
2018
Tracked investments
22

Team · 10 people

from the firm's website
Andrew McNeill· Managing Partner

Managing Partner and member of the Investment Committee.

Ana Stewart· Partner

Partner and member of the Investment Committee.

Andrew Durkie· Partner

Partner and member of the Investment Committee.

Chris Brinsmead· Partner

Partner and member of the Investment Committee.

Rick Clark· Partner

Partner and member of the Investment Committee.

Rob Halliday· Investment Director
Anne Muir· Director of Portfolio
Calum Keddie· Investment Executive
Hettie Blampied· Operations and Communications Executive
Jill Arnold· Investment Relationship Director

What they invest in

from 17 of 22 portfolio companies

Biotech ×9Healthtech ×9Medical Devices ×7Cleantech ×5Deep Tech ×5AI & Machine Learning ×3Hardware ×3New Materials ×3

HQs:United Kingdom×9Italy×1

Investments · 22 tracked

founders shown can be your intro path

By year:2024 · 12023 · 23 dated

TaiSantaisan.co.ukin✓ verified

TaiSan develops sodium batteries and works with operators, OEMs and research institutions to deploy them into vehicle fleets.

Advanced ManufacturingCleantechEnergyHardwareNew Materials

Bioliberty.Cobioliberty.co.ukin

Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to more patients.

Digital HealthMedical DevicesRobotics

Biotangents.Cobiotangents.co.uk

Biotangents develops AmpliSpec, a LAMP-based molecular diagnostics platform for veterinary use that delivers pathogen-specific results in under two hours at the point of care, in laboratories, or embedded within partner systems.

AgTechBiotechMedical Devices

Carcinotech.Cocarcinotech.co.ukinDec 2023

Carcinotech produces 3D-bioprinted tumour models using established cancer cell lines and patient-derived tissue, offering assay-ready models and preclinical oncology services for drug testing and translational research.

BiotechDeep TechHealthtechScotland

Albert Nicholl(Director)Ishani Malhotra(Executive Officer, Director)Ian David Waddell(Director)

Chemifychemify.ioin

Chemify builds automated chemical synthesis systems combining chemistry, AI, and robotics to digitize molecular design and manufacturing.

AI & Machine LearningBiotechDeep TechGlasgow, GB

Professor Lee Cronin

Concinnitygeneticsconcinnitygenetics.com

Concinnity Genetics develops control mechanisms to improve the safety of cell and gene therapies, using an AI platform and synthetic biology to help biopharmaceutical partners design and optimise their gene therapies.

AI & Machine LearningBiotechHealthtechEdinburgh, GB

Jessica Birt(Co-founder & CEO)Matthew Dale(Co-founder & CSO)

Cumulus Oncologycumulusoncology.com

Cumulus Oncology builds a risk-adjusted portfolio of preclinical-stage oncology drug assets, using a platform-agnostic, data- and milestone-driven curation process to advance cancer therapeutics for defined patient populations with high unmet medical need.

BiotechHealthtech

Clare Wareing(CEO)

Dxcoverdxcover.com

Dxcover develops a multi-omic liquid biopsy platform that combines infrared light spectroscopy and machine learning to detect multiple cancers at an early stage.

AI & Machine LearningBiotechMedical Devices

Enough Foodenough-food.comin

ENOUGH produces sustainable food ingredients and works with customers, suppliers, and partners toward its mission.

FoodTechImpact & Social Good

Ensilitechensilitech.comin

EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration.

BiotechCleantechDeep TechHealthtechMedical Devices

Asel Sartbaeva(Co-Founder & CEO)Matt Slade(Co-Founder & Chief of Staff)Stephen Wells(Co-Founder & Advisor)Aswin Doekhie(Co-Founder & CTO)Sabine Ficek(CFO)Simon Bennett(Chief Commercial Officer)

Gmflow.Cogmflow.co.ukin

GM Flow Measurement Services manufactures gas flow meters, including its adjustable differential pressure cone meter Adjusta-Cone and Hy-Cone products, for use in oil and gas production, hydrogen fuelling, and CO2 carbon capture operations.

CleantechEnergyHardware

ILC Therapeutics Ltdilctherapeutics.comin

ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform.

BiotechDeep TechHealthtechMedical Devices

Owain Millington(CEO)

Nami Surgicalnamisurgical.cominApr 2024

Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains.

HealthtechMedical DevicesRoboticsGlasgow, GB

Nico Fenu(Co-Founder & Chief Operating Officer)REBECCA CLEARY(Executive Officer, Director)NICOLA GIUSEPPE FENU(Executive Officer, Director)NIKKI PAMELA PALFREY(Director)ALBERT NICHOLL(Director)Rebecca Cleary(Co-Founder & Chief Technical Officer)

Naturbeadsnaturbeads.comin𝕏

Naturbeads develops biodegradable cellulose microspheres to replace microplastics in consumer products such as cosmetics and paints.

Circular EconomyCleantechNew MaterialsItaly, IT

Marco Meuli(Operator)Janet Scott(Co-founder)Davide Mattia(Co-founder)Giovanna Laudisio(Co-founder)

Neupulseneupulse.co
Novel Technologies

Developed technology embedding pure silver particles into fibres as an ecologically sound, non-toxic antimicrobial coating for paints and textiles.

Novosoundnovosound.netin

SenseBP is a wearable blood pressure monitoring device that eliminates the need for traditional pressure cuffs.

HardwareHealthtech

Penrhosbiopenrhosbio.com
Silverbactechsilverbactech.com

SILVERbac is a patented antimicrobial textile technology that permanently incorporates pure silver particles into fibres, making the treatment non-leaching, non-toxic, and eco-friendly.

Advanced ManufacturingCleantechHealthtechNew MaterialsDubai, GB

Wobble Genomicswobblegenomics.cominDec 2023

Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.

BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh

Joanna Smart(Director)Richard Izen Kuo(Executive Officer, Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)

Portfolio news

latest coverage across their companies

Principals & officers · per Companies House

what is this? ⓘ
Andrew Steven Durkie

LLP designated member · since 2022

Andrew Paul Mcneill

LLP designated member · since 2018

Christopher David Brinsmead

LLP member · since 2020

Richard Phillip Harley Clark

LLP member · since 2019

Ana Cristina Stewart

LLP member · since 2019

Ownership & control

Andrew Paul Mcneill25–50% of voting rights, right to share surplus assets 25 to 50 percent limited liability partnership

Frequently asked questions

What stage does Eos Advisory invest at?
Eos Advisory invests at the Seed, Series A, Growth stages.
What sectors does Eos Advisory focus on?
Eos Advisory focuses on AgTech, Biotech, Cleantech, Climate Tech, Deep Tech, Digital Health, Energy, FoodTech, Healthtech, Impact & Social Good, IoT, Medical Devices.
Where is Eos Advisory located?
Eos Advisory is headquartered in St Andrews, GB.
Does Eos Advisory lead rounds?
Eos Advisory typically participates in rounds rather than leading them.

Media · Podcasts & interviews

featuring the team

Similar investors

Featured in lists